Custom Award recognizing contributions to the development of a medical implant, and embedding the actual device within Lucite. (23AZH106)
The Corporate Presence can provide a range of commemorative designs, including those for FDA approvals, treatment studies, licensing, development, and commercialization agreements, and drug launches. We have unmatched expertise and experience in embedding drug vials.
Custom Award recognizing contributions to the development of a medical implant, and embedding the actual device within Lucite. (23AZH106)
Lucite commemorative marking the first patient dosed in a clinical study involving LunAIRo. Developed by Apnimed, the drug is intended for the treatment of obstructive sleep apnea. (23AZH173)
Diamond-shaped crystal deal toy commemorating a follow-on stock offering by Swiss biotech firm Oculis. (23AKL262)
Custom Lucite commemorative celebrating a strategic partnership involving New Jersey-based Riverside Oral Surgery. (22AZH222)
Custom Lucite commemorating seed financing for Martin Pharmaceuticals. The design replicates the packaging for LIVANTRA, an orphan drug for the treatment of Acute-on-Chronic Liver Failure (ACLF). (8AMF069)
Custom crystal celebrating FDA acceptance of the Investigational Drug Application for XTX101, a potential treatment for cancer patients.
(21AJH115)Crystal commemorative recognizing a collaboration involving Virginia Commonwealth University’s Medicine for All Institute.
(20AJH069)Crystal commemorative celebrating a development and commercialization agreement between Click Therapeutics and pharmaceutical firm Boehringer Ingelheim. The partnership centers on a mobile prescription app providing digital treatment for patients with schizophrenia.
(21AKL599)
